Hematology cprr

Ended Definitive Contract Awarded Last action

Contract number
W91YTZ22C0014
Awardee
Awarding agency
Obligated
$258,489

Award facts

Opportunity
  • W91YTZ22R0036 Solicitation number
Contract value 80% obligated
  • $316,111.95 Current, with exercised options
  • $323,111.25 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Columbia, SC 29207, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Funding Only Action P00007 $64,622
Exercise an Option P00006 · VJD umod exer OY3 cprr mahc $0
Funding Only Action P00005 · VJD umod funding hematology cprr mahc $64,622
Exercise an Option P00004 · Exer FY25 OY2 $0
Funding Only Action P00003 · FY24 OY1 ROF $64,622
Exercise an Option P00002 · MOD exer FY24 OY1 $0
Funding Only Action P00001 · FY23 ROF $64,622
Original award $0

About this award

The Defense Health Agency awarded a firm fixed-price definitive contract to Sysmex America, Inc. for hematology clinical laboratory diagnostic equipment and related services on October 1, 2022, with a ceiling value of $323,111.25 and an ultimate completion date of September 30, 2027.

Place of performance is Columbia, SC 29207. The originating solicitation procures hematology analyzer systems, reagents, consumables, and maintenance support for federal healthcare laboratory operations. Sysmex America is a large-business subsidiary of Japan-headquartered Sysmex Corporation, competing in NAICS 339112 (Surgical Appliance and Supplies Manufacturing) and 334516 (Analytical Laboratory Instrument Manufacturing), with primary PSC 6520 (Laboratory Equipment and Supplies). The company operates as a prime contractor across federal healthcare agencies, delivering hematology analyzers (XN-1000, XN-3100, XN1000BB models), urinalysis systems, digital morphology solutions, and comprehensive maintenance services predominantly on cost-per-reportable-result and cost-per-test bases. Sysmex anchors its federal healthcare work on the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III), which carries combined task-order potential value of $632 million through December 2029.

Quick answers

Who was awarded contract W91YTZ22C0014?

W91YTZ22C0014 was awarded to Sysmex America, Inc. by Medical Command (Department of the Army) on October 1, 2022.

How much is contract W91YTZ22C0014 worth?

The government has obligated $258,489 on W91YTZ22C0014. Its current value, with exercised options, is $316,112. Its potential value, with all options, is $323,111.

Which agency awarded contract W91YTZ22C0014?

Medical Command (Department of the Army) awarded W91YTZ22C0014, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ22C0014 competed?

The extent of competition for W91YTZ22C0014 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award